小陷胸汤合补阳还五汤治疗早期糖尿病肾病临床观察

王涓涓; 邵岩; 韩向莉; 张艳; 蔡井阳; 常柏

doi:10.13422/j.cnki.syfjx.2016210152

您当前的位置：

首页 >

文章列表页 >

小陷胸汤合补阳还五汤治疗早期糖尿病肾病临床观察

临床 | 更新时间：2024-01-04

- 小陷胸汤合补阳还五汤治疗早期糖尿病肾病临床观察
- Clinical Observation of Xiaoxianxiong Tang Combined with Buyang Huanwu Tang in Treatment of Early Diabetic Nephropathy
- 中国实验方剂学杂志 2016年22卷第21期页码：152-156
- 作者机构：
- 作者简介：
- 基金信息：
  
  国家自然科学基金面上项目（81273914）
- DOI：10.13422/j.cnki.syfjx.2016210152
  中图分类号： R259
- 纸质出版日期：2016
- 稿件说明：
移动端阅览
王涓涓, 邵岩, 韩向莉, 等. 小陷胸汤合补阳还五汤治疗早期糖尿病肾病临床观察[J]. 中国实验方剂学杂志, 2016,22(21):152-156.

WANG Juan-juan, SHAO Yan, HAN Xiang-li, et al. Clinical Observation of Xiaoxianxiong Tang Combined with Buyang Huanwu Tang in Treatment of Early Diabetic Nephropathy[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(21): 152-156.
王涓涓, 邵岩, 韩向莉, 等. 小陷胸汤合补阳还五汤治疗早期糖尿病肾病临床观察[J]. 中国实验方剂学杂志, 2016,22(21):152-156. DOI： 10.13422/j.cnki.syfjx.2016210152.

WANG Juan-juan, SHAO Yan, HAN Xiang-li, et al. Clinical Observation of Xiaoxianxiong Tang Combined with Buyang Huanwu Tang in Treatment of Early Diabetic Nephropathy[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(21): 152-156. DOI： 10.13422/j.cnki.syfjx.2016210152.

摘要

目的：观察小陷胸汤合补阳还五汤治疗早期糖尿病肾病的临床疗效，并探讨其作用机制。方法：将86例患者随机分为治疗组和对照组，各43例，治疗组口服小陷胸汤合补阳还五汤，对照组口服替米沙坦40 mg/次，1次/d，两组疗程均为6个月。观察两组临床疗效、中医证候积分，并检测治疗前后尿白蛋白排泄率（UAER），血清肌酐（SCr），血尿素氮（BUN），空腹血糖（FBG），总胆固醇（TC），甘油三酯（TG），低密度脂蛋白（LDL）及高密度脂蛋白（HDL）。结果：治疗组总有效率（87.8%）优于对照组（62.7%）（P<0.05）；两组症状疗效改善率差异显著（P<0.05，P<0.01）；治疗组治疗后UAER，SCr，BUN，FBG，TC，TG，LDL均明显低于治疗前（P<0.05，P<0.01），HDL较治疗前明显升高（P<0.05）；治疗组治疗后与对照组比较，UAER，SCr，BUN，FBG有降低趋势；TC，TG，LDL降低，HDL升高（P<0.05）。结论：小陷胸汤合补阳还五汤结合西医基础治疗早期糖尿病肾病有较好的疗效。

Abstract

Objective: To observe the clinical efficacy of Xiaoxianxiong Tang combined with Buyang Huanwu Tang in treating early diabetic nephropathy. Method: Totally 86 patients were randomly divided into treatment group (43 cases

treated with Xiaoxianxiong Tang combined with Buyang Huanwu Tang) and control group (43 cases

treated with telmisartan

40 mg per day). All patients were treated for 6 months. The changes in therapeutic efficacy

Chinese medicine syndrome scores

urinary albumin excretion rate (UAER)

serum creatinine (SCr)

blood urea nitrogen (BUN)

fasting blood glucose (FBG)

total cholesterol (TC)

glycerol triester (TG)

low-density lipoprotein (LDL)

high-density lipoprotein (HDL) were observed. Result: The total effective rate in treatment group was 87.8%

which was obviously higher than that in control group (62.7%) (P<0.05)

with significant difference in efficacy improvement and symptom alleviation rates between the two groups (P<0.05

P<0.01). In treatment group

levels of UAER

SCr

BUN

FBG

LDL decreased significantly after treatment than before treatment (P<0.05

P<0.01)

HDL increased significantly after treatment than before treatment (P<0.05). Compare with control group

levels of UAER

SCr

BUN

FBG decreased

and levels of TC

LDL decreased

and levels of HDL increased (P<0.05) after treatment in treatment group. The aforesaid indexes were also improved in the control group after treatment (P<0.05

P<0.01). Conclusion: Xiaoxianxiong Tang combined with Buyang Huanwu Tang show a better therapeutic efficacy on early diabetic nephropathy.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

HIF-1α在糖尿病肾病中的机制研究及中医药改善作用的研究进展

保肾方治疗气阴两虚、肾络瘀阻证糖尿病肾病Ⅳ期的随机对照试验

基于EGFR/PI3K/Akt信号通路探讨黄连-麦冬药对延缓糖尿病肾病的作用机制

中药基于NF-κB信号通路干预改善糖尿病肾病的研究进展

大黄糖络丸调控AGEs/RAGE/IKK/NF-κB通路改善糖尿病肾病小鼠肾脏炎症损伤的机制